SCHEMBL50712

SCHEMBL50712

Oc1ccc(Pc2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.56
CA1 P00915 2/20 0.56
CA2 P00918 2/20 0.56
CA3 P07451 2/20 0.56
CA4 P22748 2/20 0.56
CA9 Q16790 2/20 0.56
CA14 Q9ULX7 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
GLA P06280 1/20 0.56
MMP3 P08254 1/20 0.52
BCL2L1 Q07817 1/20 0.52
MEN1 O00255 2/20 0.47
NPC1 O15118 2/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 2/20 0.47
CYP3A4 P08684 2/20 0.47
KDM4E B2RXH2 1/20 0.47
GMNN O75496 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL28820447 0.97 CA12 (0.53) CA12CA1CA2CA3CA4
Hydroquinone SCHEMBL9287383 0.97 CA12 (0.59) CA12CA1CA2CA3CA4
Hydroquinone SCHEMBL16266999 0.97 CA12 (0.59) CA12CA1CA2CA3CA4
Hydroquinone SCHEMBL7648401 0.97 CA12 (0.59) CA12CA1CA2CA3CA4
Phenol SCHEMBL18486356 0.91 CA12 (0.69) CA12CA1CA2CA3CA4
SCHEMBL10494067 0.87 TDP1 (0.41) CA12CA1CA2CA3CA4
SCHEMBL5966291 0.87 ALOX15 (0.61) CA12CA1CA2CA3CA4
Benzene SCHEMBL4445625 0.84 TDP1 (0.44) CA12CA1CA2CA3CA4
Benzene SCHEMBL28943358 0.84 TDP1 (0.44) CA12CA1CA2CA3CA4
SCHEMBL49343 0.84 TDP1 (0.44) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110462818-A SEALING FILM, METHOD FOR MANUFACTURING ELECTRONIC COMPONENT DEVICE, AND ELECTRONIC COMPONENT DEVICE HITACHI CHEMICAL CO LTD 2019-11-15 CN disclosed
CN-107207705-B Epoxy resin composition, film-shaped epoxy resin composition, cured product, and electronic device HITACHI CHEMICAL CO.,LTD. (JP) 2019-11-01 CN disclosed
CN-106458834-B Diphenyl carbonate and method for producing same, catalyst and method for producing, recovering and reusing same, and polycarbonate 三菱化学株式会社 2019-10-25 CN disclosed
CN-105339410-B The manufacturing method of membranaceous composition epoxy resin, the manufacturing method of membranaceous composition epoxy resin and semiconductor device 日立化成株式会社 2019-08-20 CN disclosed
CN-109942628-A A kind of synthetic method of tetraphenyl phosphine phenolate 临沂康爱特化工科技有限公司 2019-06-28 CN disclosed
CN-109942628-A A kind of synthetic method of tetraphenyl phosphine phenolate 临沂康爱特化工科技有限公司 2019-06-28 CN disclosed
CN-107868276-A A kind of stabiliser compositions for being used to prepare polycarbonate compositions 中蓝晨光化工研究设计院有限公司 2018-04-03 CN disclosed
CN-107207705-A Epoxy resin composition, film-shaped epoxy resin composition, cured product, and electronic device 日立化成株式会社 2017-09-26 CN disclosed
CN-104893539-B Preparation method of hydrophobic and flame-retardant PU (polyurethane) coating 西安科技大学 2017-04-19 CN disclosed
CN-106458834-A Diphenyl carbonate and method for producing same, catalyst and method for producing, recovering and reusing same, and polycarbonate 三菱化学株式会社 2017-02-22 CN disclosed
US-7666953-B2 Phosphine-protonated haloaromatic compound accelerator with curing resin and curing agent HITACHI CHEMICAL CO, LTD. (JP) 2010-02-23 US disclosed
US-20090062460-A1 CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE HITACHI CHEMICAL CO., LTD. (JP) 2009-03-05 US disclosed
US-20090005480-A1 REACTION PRODUCT OF PHOSPHINE AND PROTONATED HALOARYL COMPOUND AND USE AS EPOXY CURING ACCELERATOR NAKAMURA SHINYA 2009-01-01 US disclosed
CN-100432081-C Novel hydroxyaryl phosphine oxides,diglycidyl ethers and epoxy compositions, composites and laminates derived therefrom PABU SERVICES INC (US) 2008-11-12 CN disclosed
US-20080262135-A1 REACTION PRODUCT OF PHOSPHINE AND PROTONATED HALOARYL COMPOUND AND USE AS EPOXY CURING ACCELERATOR SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-10-23 US disclosed
CN-100349903-C Novel hydroxyarylphosphine oxide, glycidyl ether and epoxy compositions and composites and laminates derived therefrom PABU SERVICES INC (US) 2007-11-21 CN disclosed
CN-1743336-A Novel hydroxyaryl phosphine oxides,diglycidyl ethers and epoxy compositions, composites and laminates derived therefrom PABU SERVICES INC (US) 2006-03-08 CN disclosed
CN-1533396-A Novel hydroxyarylphosphine oxide, glycidyl ether and epoxy compositions and composites and laminates derived therefrom 2004-09-29 CN disclosed
EP-1240232-A1 METHOD FOR PRODUCING POLYCARBONATE Bayer Aktiengesellschaft (DE) 2002-09-18 EP disclosed
WO-2001036511-A1 METHOD FOR PRODUCING POLYCARBONATE BAYER AKTIENGESELLSCHAFT (DE) 2001-05-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062460-A1 CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE NCAPH, RAD51, H1-2 CA12 2683/4885CA1 1198/4885CA2 2179/4885
US-20090005480-A1 REACTION PRODUCT OF PHOSPHINE AND PROTONATED HALOARYL COMPOUND AND USE AS EPOXY CURING ACCELERATOR HDHD5, EHMT2, HRH2 CA12 3320/4885CA1 3299/4885CA2 3260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.